Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Metabolic adverse events in patients with mental illness treated with antipsychotics: a primary care perspective.

Balf G, Stewart TD, Whitehead R, Baker RA.

Prim Care Companion J Clin Psychiatry. 2008;10(1):15-24.

2.

[Schizophrenia, diabetes mellitus and antipsychotics].

Gury C.

Encephale. 2004 Jul-Aug;30(4):382-91. Review. French.

PMID:
15538314
3.
4.

Atypical antipsychotics and glucose homeostasis.

Bergman RN, Ader M.

J Clin Psychiatry. 2005 Apr;66(4):504-14. Review.

PMID:
15816794
5.

Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of schizophrenia and related disorders.

Royal Australian and New Zealand College of Psychiatrists Clinical Practice Guidelines Team for the Treatment of Schizophrenia and Related Disorders.

Aust N Z J Psychiatry. 2005 Jan-Feb;39(1-2):1-30. Review.

PMID:
15660702
6.

Metabolic syndrome and mental illness.

Newcomer JW.

Am J Manag Care. 2007 Nov;13(7 Suppl):S170-7. Review. Erratum in: Am J Manag Care. 2008 Feb;14(2):76.

7.

Weight gain and glucose dysregulation with second-generation antipsychotics and antidepressants: a review for primary care physicians.

Hasnain M, Vieweg WV, Hollett B.

Postgrad Med. 2012 Jul;124(4):154-67. doi: 10.3810/pgm.2012.07.2577. Review.

PMID:
22913904
8.

Long-term health considerations in schizophrenia: metabolic effects and the role of abdominal adiposity.

Van Gaal LF.

Eur Neuropsychopharmacol. 2006 Sep;16 Suppl 3:S142-8. Epub 2006 Jul 24. Review.

PMID:
16863690
9.

Metabolic abnormalities associated with second generation antipsychotics: fact or fiction? Development of guidelines for screening and monitoring.

De Hert M, van Eyck D, De Nayer A.

Int Clin Psychopharmacol. 2006 Mar;21 Suppl 2:S11-5. Review.

PMID:
16601508
10.

Primary prevention of cardiovascular events in patients with major mental illness: a possible role for statins.

Andrade C.

Bipolar Disord. 2013 Dec;15(8):813-23. doi: 10.1111/bdi.12130. Epub 2013 Oct 10. Review.

PMID:
24119211
11.

Antipsychotic medications: metabolic and cardiovascular risk.

Newcomer JW.

J Clin Psychiatry. 2007;68 Suppl 4:8-13. Review.

12.
13.

Obesity and related metabolic abnormalities during antipsychotic drug administration: mechanisms, management and research perspectives.

Baptista T, Kin NM, Beaulieu S, de Baptista EA.

Pharmacopsychiatry. 2002 Nov;35(6):205-19. Review.

PMID:
12518268
14.

Guideline concordant monitoring of metabolic risk in people treated with antipsychotic medication: systematic review and meta-analysis of screening practices.

Mitchell AJ, Delaffon V, Vancampfort D, Correll CU, De Hert M.

Psychol Med. 2012 Jan;42(1):125-47. doi: 10.1017/S003329171100105X. Epub 2011 Aug 10. Review.

PMID:
21846426
15.

Schizophrenia and comorbid metabolic disorders.

Henderson DC.

J Clin Psychiatry. 2005;66 Suppl 6:11-20. Review.

16.

Nursing care of clients treated with atypical antipsychotics who have a risk of developing metabolic instability and/or type 2 diabetes.

Edward KL, Rasmussen B, Munro I.

Arch Psychiatr Nurs. 2010 Feb;24(1):46-53. doi: 10.1016/j.apnu.2009.04.009. Epub 2009 Aug 6. Review.

PMID:
20117688
17.

Quality of care for cardiovascular disease and diabetes amongst individuals with serious mental illness and those using antipsychotic medications.

Scott D, Platania-Phung C, Happell B.

J Healthc Qual. 2012 Sep-Oct;34(5):15-21. doi: 10.1111/j.1945-1474.2011.00155.x. Epub 2011 Aug 2. Review.

PMID:
22092725
18.

Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.

Alexander KP, Newby LK, Cannon CP, Armstrong PW, Gibler WB, Rich MW, Van de Werf F, White HD, Weaver WD, Naylor MD, Gore JM, Krumholz HM, Ohman EM; American Heart Association Council on Clinical Cardiology; Society of Geriatric Cardiology.

Circulation. 2007 May 15;115(19):2549-69. Review.

19.

[Therapeutic options for weight management in schizophrenic patients treated with atypical antipsychotics].

Cordes J, Sinha-Röder A, Kahl KG, Malevani J, Thuenker J, Lange-Asschenfeldt C, Hauner H, Agelink MW, Klimke A.

Fortschr Neurol Psychiatr. 2008 Dec;76(12):703-14. doi: 10.1055/s-2008-1038279. Epub 2008 Oct 15. Review. German.

PMID:
18924059
20.

Metabolic and endocrine disturbances in psychiatric disorders: a multidisciplinary approach to appropriate atypical antipsychotic utilization.

Masand PS, Culpepper L, Henderson D, Lee S, Littrell K, Newcomer JW, Rasgon N.

CNS Spectr. 2005 Oct;10(10):suppl14 1-15.

PMID:
16404802

Supplemental Content

Support Center